The Prostate Working Group is led by Dr. Bob Dess, Dr. Dave Heimburger, and Dr. Dale Litzenberg. The pilot initiative launched in July 2020 and has expanded to include the larger Michigan Radiation Oncology Quality Consortium in  2021. The Prostate Group is working to minimize overutilization of unnecessary resources in localized prostate to advance value-based care.

Areas of Current & Ongoing Focus:

  • Increase usage of active surveillance in patients with low risk disease
  • Increase usage of guide concordant, cost effective radiation forms of radiation
  • Decrease unnecessary hormone therapy administration and pelvic lymph node radiation
  • Appropriate usage of staging scans